Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
| ▸ | GRM5 | P41594 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21702013 | 0.94 | MAOB (0.37) | ADORA2AADORA1 | |
| SCHEMBL21701977 | 0.85 | PDK2 (0.36) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL21701687 | 0.84 | ADORA3 (0.30) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL21151247 | 0.83 | ADORA3 (0.35) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL22908045 | 0.82 | ADORA3 (0.35) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL21702199 | 0.82 | ABCG2 (0.39) | TSHR | |
| SCHEMBL21701915 | 0.80 | MEN1 (0.36) | ADORA2AADORA1 | |
| SCHEMBL21701888 | 0.79 | ABCG2 (0.37) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL24518629 | 0.79 | FABP1 (0.35) | ALOX15TSHR | |
| SCHEMBL24518736 | 0.78 | TNF (0.51) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200048230-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME | LG CHEM, LTD. (KR) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048230-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME | CRY1, CRY2, CYP1A1 | ADORA3 4020/4885ALOX15 150/4885TSHR 4306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.